[HTML][HTML] Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches
C Saury, A Lardenois, C Schleder, I Leroux… - Stem cell research & …, 2018 - Springer
Abstract Background Canine MuStem cells have demonstrated regenerative efficacy in a
dog model of muscular dystrophy, and the recent characterization of human counterparts …
dog model of muscular dystrophy, and the recent characterization of human counterparts …
A comparative study of pathogen inactivation technologies in human platelet lysate and its optimal efficiency in human placenta-derived stem cells culture
E Razani, HR Aghayan, S Alavi-Moghadam… - Journal of Virological …, 2022 - Elsevier
Background Pathogen inactivation (PI) is necessary for the pooled components derived from
a biological source. Recently, the use of human platelet lysate (hPL) has increased in the …
a biological source. Recently, the use of human platelet lysate (hPL) has increased in the …